Research
By the numbers
27 peer-reviewed publications · 5 textbook chapters · 21 conference presentations at national and international conferences including COA, OTA, AAOS, and AAN · Active peer-reviewer for 8 journals including BMJ Open
Full text publication link
Research Themes
Health equity in arthroplasty
A 2023 paper in the Journal of Arthroplasty looked at how socioeconomic marginalization affects who gets access to total joint replacement in Canada — and what happens to outcomes and discharge destination when they do. This work reflects a core conviction: universal healthcare should mean what it says.
AI and technology in orthopaedic surgery
Dr. Rubinger co-authored a 2023 paper in Injury on machine learning and AI in research and healthcare. He thinks seriously about where technology is improving surgical outcomes, where it's being oversold, and how to tell the difference.
Virtual care and access to treatment
He was publishing on virtual care in orthopaedics in 2021 — before it became unavoidable — and has continued to think about how remote tools can expand access to expertise for patients who don't live near a major academic centre.
Perioperative optimization
Research on pain management strategies — including a 2023 systematic review on quadratus lumborum block for postoperative pain in hip replacement — return to work, and recovery optimization.
Innovation & Investment
iGAN Partners
Dr. Rubinger sits on the Clinical and Commercial Advisory Board of iGAN Partners, one of Canada's largest healthcare-focused venture capital firms. He provides clinical and strategic guidance to portfolio companies working on health innovation.
Halo Health
Dr. Rubinger sits on the board of Halo Health, a company focused on improving how care teams communicate and coordinate across hospital settings — reducing gaps in communication that affect patient safety and care continuity.
The bigger picture
His third pillar — alongside surgery and research — is developing care pathways that give patients faster, more equitable access to orthopaedic care. That means investing in the companies building better tools, and building the clinical and administrative systems that make those tools accessible to patients who need them most.